|
trichlormethiazide and potassium
|
C03AB06 |
|
|
polythiazide and potassium
|
C03AB05 |
|
|
methyclothiazide and potassium
|
C03AB08 |
|
|
cyclopenthiazide and potassium
|
C03AB07 |
|
|
Alpha- and beta-adrenoreceptor agonists
|
R03CA |
|
|
cyclothiazide and potassium
|
C03AB09 |
|
|
Selective beta-2-adrenoreceptor agonists
|
R03CC |
|
|
Non-selective beta-adrenoreceptor agonists
|
R03CB |
|
|
lamivudine and tenofovir disoproxil
|
J05AR12 |
|
|
lamivudine, tenofovir disoproxil and efavirenz
|
J05AR11 |
|
|
darunavir and cobicistat
|
J05AR14 |
|
|
lamivudine, abacavir and dolutegravir
|
J05AR13 |
|
|
lamivudine and raltegravir
|
J05AR16 |
|
|
Thiazides, combinations with psycholeptics and/or analgesics
|
C03AH |
|
|
atazanavir and cobicistat
|
J05AR15 |
|
|
Other antimigraine preparations
|
N02CX |
|
|
Adrenergics and other drugs for obstructive airway diseases
|
R03CK |
|
|
emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
|
J05AR18 |
|
|
emtricitabine and tenofovir alafenamide
|
J05AR17 |
|
|
fluorometholone
|
S01CB05 |
|
